Neuroprotective substances: are they able to protect the pancreatic beta-cells too?

RU Ostrovskaya, SV Ivanov - Endocrine, Metabolic & Immune …, 2022 - ingentaconnect.com
Background: Growing pieces of evidence demonstrate a close relationship between type 2
diabetes (T2D) and neurodegenerative disorders such as Alzheimer's disease. The …

[HTML][HTML] Inonotus obliquus polysaccharide ameliorates serum profiling in STZ-induced diabetic mice model

T Xu, G Li, X Wang, C Lv, Y Tian - BMC chemistry, 2021 - Springer
Background Diabetes mellitus is a systemic disease mainly caused by the disorder of
metabolism, which has become huge threat to human health. Polysaccharides are the main …

Дипептидный препарат ноопепт: дизайн, фармакологические свойства и механизм действия

РУ Островская, ТА Гудашева - Экспериментальная и клиническая …, 2021 - ekf.folium.ru
Аннотация Представлен обзор собственных работ, который посвящен истории
создания, фармакологическим и клиническим свойствам ноотропного дипептидного …

Neuroprotective dipeptide noopept prevents DNA damage in mice with modeled prediabetes

RU Ostrovskaya, SS Yagubova, AK Zhanataev… - Bulletin of Experimental …, 2019 - Springer
In experiments on BALB/c mice, prediabetes was modeled by administration of
streptozotocin in a dose of 130 mg/kg. DNA damage was assessed by the method of DNA …

Antidiabetic activity of Afobazole in Wistar rats

RU Ostrovskaya, SV Ivanov, MV Voronin… - Bulletin of Experimental …, 2018 - Springer
Using the streptozotocin model of type 2 diabetes mellitus in Wistar rats, we compared
antidiabetic activity of anxiolytic Afobazole with that of metformin. Afobazole in a dose of 10 …